- Home
- SNTI vs SWVL Comparison
SNTI vs SWVL Comparison
Compare SNTI & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- SWVL
- Stock Information
- Founded
- SNTI 2016
- SWVL 2017
- Country
- SNTI United States
- SWVL United Arab Emirates
- Employees
- SNTI N/A
- SWVL N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- SNTI Health Care
- SWVL Consumer Discretionary
- Exchange
- SNTI Nasdaq
- SWVL Nasdaq
- Market Cap
- SNTI 39.6M
- SWVL 37.6M
- IPO Year
- SNTI N/A
- SWVL N/A
- Fundamental
- Price
- SNTI $1.37
- SWVL $3.58
- Analyst Decision
- SNTI Strong Buy
- SWVL
- Analyst Count
- SNTI 2
- SWVL 0
- Target Price
- SNTI $8.50
- SWVL N/A
- AVG Volume (30 Days)
- SNTI 120.0K
- SWVL 15.4K
- Earning Date
- SNTI 11-13-2025
- SWVL 09-08-2025
- Dividend Yield
- SNTI N/A
- SWVL N/A
- EPS Growth
- SNTI N/A
- SWVL N/A
- EPS
- SNTI N/A
- SWVL N/A
- Revenue
- SNTI N/A
- SWVL $19,329,423.00
- Revenue This Year
- SNTI N/A
- SWVL N/A
- Revenue Next Year
- SNTI $150.00
- SWVL N/A
- P/E Ratio
- SNTI N/A
- SWVL N/A
- Revenue Growth
- SNTI N/A
- SWVL N/A
- 52 Week Low
- SNTI $1.26
- SWVL $2.40
- 52 Week High
- SNTI $16.94
- SWVL $7.50
- Technical
- Relative Strength Index (RSI)
- SNTI 37.01
- SWVL 45.34
- Support Level
- SNTI $1.33
- SWVL $3.31
- Resistance Level
- SNTI $1.39
- SWVL $4.01
- Average True Range (ATR)
- SNTI 0.08
- SWVL 0.29
- MACD
- SNTI 0.01
- SWVL 0.01
- Stochastic Oscillator
- SNTI 31.43
- SWVL 38.44
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.